ConductScience.org, home

Paper7523947

Immunosuppression in liver transplantation.

Calne RY. N Engl J Med, 1994. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. Immunosuppression in liver transplantation. Papers, record 7523947. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7523947

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunosuppression in liver transplantation.
PubMed
Journal
N Engl J Med
PubMed
Year
1994
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
0.72
iCite
Revised in PubMed
2021-12-03
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Calne RYR Y

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Immunosuppression TherapyMajor topic
Liver TransplantationMajor topic
Graft Rejection
Graft Survival
Humans
Tacrolimus

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on7523946A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.https://conductscience.org/library/papers/7523946

Source PubMed

Download CSV of comments and corrections

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
28926189Environmental peer pressure: CD4+ T cell help in tolerance and transplantation.Liver Transpl2018https://conductscience.org/library/papers/28926189PubMed
26794038Liver sinusoidal endothelial cells induce tolerance of autoreactive CD4+ recent thymic emigrants.Sci Rep2016https://conductscience.org/library/papers/26794038PubMed
26202415Everolimus-based immunosuppression in liver transplant recipients: a single-centre experience.Hepatol Int2014https://conductscience.org/library/papers/26202415PubMed
24426203Lipid parameters, doses and blood levels of calcineurin inhibitors in renal transplant patients.Indian J Clin Biochem2013https://conductscience.org/library/papers/24426203PubMed
23560160Risk factors of post endoscopic retrograde cholangiopancreatography bacteremia.Gut Liver2013https://conductscience.org/library/papers/23560160PubMed
21912452Dual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studies.World J Gastroenterol2011https://conductscience.org/library/papers/21912452PubMed
18669892Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance.Blood2008https://conductscience.org/library/papers/18669892PubMed
7558153Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells.Immunology1995https://conductscience.org/library/papers/7558153PubMed
7475777Randomised trialomania? The multicentre liver transplant trials of tacrolimus.Lancet1995https://conductscience.org/library/papers/7475777PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7523947

GET https://conductscience.org/api/papers/v1/7523947/authors